Skip to main content
BBIO filings

Corporate insider profile

Randal W. Scott Filing Activity

Latest reported as Corporate insider of BridgeBio Pharma, Inc. (BBIO).

Purchase filings
0
Reported companies
1
Net open-market value
-$671,456.00
Latest transaction
May 15, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 15, 2026BridgeBio Pharma, Inc. (BBIO)Corporate insiderSale10,000$67.15$671,456